Development Level

Tclin 5 | 613
Tchem 2 | 1,598
Tbio 1 | 11,445

IMPC Phenotype

abnormal behavior 1 | 298
decreased circulating LDL chol... 1 | 38
decreased circulating alanine ... 1 | 47
decreased fasted circulating g... 1 | 65
decreased prepulse inhibition 1 | 82
decreased startle reflex 1 | 75
decreased vertical activity 1 | 208
hyperactivity 1 | 148
improved glucose tolerance 1 | 79

Disease

Carcinoma 6 | 11,493
Cerebrovascular disease 6 | 238
Cerebrovascular Occlusion 4 | 5
Hypertension 4 | 396
Hypertensive disorder 4 | 56
Percutaneous coronary intervention 4 | 9
Peripheral vascular disease 4 | 87
Prevention of Cerebral Thrombosis 4 | 29
Subacute Stent Thrombosis Prevention 4 | 5
adult high grade glioma 4 | 3,801
glioblastoma 4 | 5,792
medulloblastoma, large-cell 4 | 6,241
primitive neuroectodermal tumor 4 | 3,035
Acute exacerbation of asthma 3 | 14
Administration of Local Anesthetic Nerve Block 3 | 14
Alcoholic Intoxication, Chronic 3 | 289
Allergic Reactions 3 | 7
Asthma management 3 | 19
Astrocytoma, Pilocytic 3 | 3,081
Attention deficit hyperactivity disorder 3 | 278
Bronchiectasis 3 | 64
Bronchitis 3 | 43
Cerebral Ischemia 3 | 37
Conscious sedation 3 | 10
Coronary artery disease 3 | 268
Dermal Necrosis 3 | 6
Diagnostic Test for Pheochromocytoma 3 | 6
Disorder of blood vessel 3 | 4
Dyspnea 3 | 76
Epilepsy 3 | 792
Exacerbation of asthma 3 | 11
Hypertension Secondary to Pheochromocytoma 3 | 6
Hypertensive Emergencies 3 | 10
Increased Intraocular Pressure after Ocular Procedure 3 | 3
Local anesthesia, by infiltration 3 | 14
Low blood pressure 3 | 9
Mood Disorders 3 | 184
Muscle Spasticity of Cerebral Origin 3 | 8
Muscle spasticity of spinal origin 3 | 8
Nasal congestion 3 | 21
Nasal discharge 3 | 24
Ocular Itching 3 | 4
Ocular hypertension 3 | 42
Open-angle glaucoma 3 | 27
Orthostatic hypotension 3 | 9
Parkinson's disease 3 | 392
Paroxysmal hypertension 3 | 6
Persistent pulmonary hypertension of the newborn 3 | 8
Pheochromocytoma 3 | 24
Prevention of Hypertension in Pheochromocytoma 3 | 6
Pulmonary emphysema 3 | 48
Red eye 3 | 7
Rosacea 3 | 25
Severe pain 3 | 11
Spasticity 3 | 26
Wheezing 3 | 7
anaphylaxis 3 | 11
atypical teratoid / rhabdoid tumor 3 | 5,112
diabetes mellitus 3 | 1,728
ependymoma 3 | 4,679
lung adenocarcinoma 3 | 2,716
lung cancer 3 | 4,740
oligodendroglioma 3 | 2,850
osteosarcoma 3 | 7,950
ovarian cancer 3 | 8,520
psoriasis 3 | 6,694
Acquired metabolic disease 2 | 336
Anorexia nervosa 2 | 80
Asthma 2 | 385
Bipolar Disorder 2 | 666
Cancer 2 | 2,499
Cardiomegaly 2 | 116
Depressive disorder 2 | 409
Fibrosis 2 | 44
Gilles de la Tourette syndrome 2 | 47
Hypertensive disease 2 | 292
Hypoglycemia 2 | 152
Hypotension 2 | 82
Intellectual disability 2 | 1,016
Mental Depression 2 | 333
Myocardial Infarction 2 | 151
Obesity 2 | 678
Pain agnosia 2 | 104
Panic disorder 2 | 61
Schizophrenia 2 | 1,160
Thrombosis 2 | 46
Weight decreased 2 | 103
cystic fibrosis 2 | 1,696
ductal carcinoma in situ 2 | 1,745
fibroadenoma 2 | 559
group 3 medulloblastoma 2 | 4,104
group 4 medulloblastoma 2 | 1,855
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
invasive ductal carcinoma 2 | 2,951
lung carcinoma 2 | 2,843
non-small cell lung cancer 2 | 2,890
pituitary cancer 2 | 1,972
tuberculosis 2 | 2,010
Gastroparesis 1 | 22
Ovarian Cysts 1 | 41

Tissue

Endocrine System 8 | 18,159
Respiratory system 8 | 16,393
Digestive Tract 7 | 17,369
Female tissues 7 | 17,400
Liver and Pancreas 7 | 16,750
Skin and soft tissues 7 | 17,230
Cardiovascular System 6 | 15,192
Male tissues 6 | 17,142
Nervous System 6 | 16,725
Urinary Tract 6 | 16,678
Blood and immune system 5 | 16,909

Target Family

GPCR 7 | 408
Non-IDG 1 | 12,091

GO Process

negative regulation of norepin... 8 | 8
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Alpha-2A adrenergic receptor ADRA2A Tclin GPCR -2.42160 261.4 232
Alpha-2B adrenergic receptor ADRA2B Tclin GPCR -2.15839 139.8 0
Growth hormone secretagogue receptor type 1 GHSR Tclin GPCR -2.70721 350.2 181
Alpha-2C adrenergic receptor ADRA2C Tclin GPCR -1.97108 93.5 343
Type-2 angiotensin II receptor AGTR2 Tchem GPCR -3.30172 1972.1 147
Corticoliberin CRH Tbio Non-IDG -3.74045 5758.6 386
P2Y purinoceptor 12 P2RY12 Tclin GPCR -3.19274 1507.4 135
P2Y purinoceptor 1 P2RY1 Tchem GPCR -2.55590 345.6 255